Israeli maker of GlucoTrack believes its noninvasive meter will encourage people with Type 2 diabetes to check glucose levels more often.
Originally published in Israel21C:
The Israeli company Integrity Applications put more than a decade into developing GlucoTrack, described as the first truly noninvasive system for self-monitoring glucose levels.
Instead of drawing blood, you clip the GlucoTrack sensor to your earlobe. A patented combination of ultrasonic, electromagnetic and thermal technologies works with a proprietary algorithm to measure physiological parameters correlated with glucose level.
Results are displayed within about a minute on a USB-connected handheld control unit, which also stores and compares previous readings. The number is announced verbally, facilitating use by elderly and vision-impaired people with diabetes or pre-diabetes.
GlucoTrack DF-F is intended for adults over the age of 18 with Type 2 diabetes or pre-diabetes. Sales in Australia and New Zealand began in 2016.
The device costs $2,000 and each ear clip costs $120. Avner Gal, Founder and CEO, estimates that over five years, people using GlucoTrack can anticipate saving significantly over the cost of five daily invasive measurements using test strips.
Integrity is working on additional GlucoTrack models including devices for developing countries, nighttime and continuous monitoring of glucose levels and an alert device for drivers. A wireless model compatible with the current device also is under development.
Known as the ‘silent pandemic’, around 1.7 million Australians suffer from diabetes, and 85% of sufferers have Type 2 diabetes.